Search clinical trials for: Nonsteroidal Anti-Androgens

Total 88514 results

Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Prostate Cancer

United States, Canada
H. Lee Moffitt Cancer Center and Research Institute
Sanofi

Terminated

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

Prostate Cancer

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Sanofi

Completed

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Prostate Cancer

United States
Jena University Hospital
Bayer

Recruiting

A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients (ARASAFE)

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Germany
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); A...

Completed

Influence of Male Hormones on Regional Fat Metabolism

Obesity

United States
Washington University School of Medicine
Solvay Pharmaceuticals

Completed

Exercise and Testosterone Therapy in Elderly Men With Physical Frailty

Hypogonadism | Hip Fracture | Physical Frailty | Elective Hip Replacement

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...
European Institute of Oncology; ASST Santi Paolo e Carlo

Recruiting

Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment (APPROACH)

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Italy
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer (CHAARTED)

Metastatic Hormone-sensitive Prostate Cancer

United States
Medical College of Wisconsin

Completed

Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation

Prostate Cancer

United States
Northwestern University
National Cancer Institute (NCI)

Recruiting

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate Carcinoma

United States
SELARL du Dr Jacques BUVAT
Bayer

Completed

Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone

Erectile Dysfunction | Hypogonadism

France
Dana-Farber Cancer Institute
Sanofi

Completed

Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

Prostate Cancer

United States
German Oncology Center, Cyprus

Active, not recruiting

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer (Hypo-Combi)

Prostate Adenocarcinoma | Radiation Toxicity

Cyprus
Kessler Foundation
United States Department of Defense

Unknown

TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males

Spinal Cord Injury

United States
Case Comprehensive Cancer Center
National Institutes of Health (NIH)

Not yet recruiting

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Prostate Cancer | Malignant Neoplasm of Prostate | Secondary Malignant Neoplasm of Prostate

United States
Memorial Sloan Kettering Cancer Center

Completed

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Cancer | Prostate | Hormonal Cycling

United States
University Hospital, Clermont-Ferrand

Recruiting

Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill (TestICUs)

Critical Illness

France
University of Michigan Rogel Cancer Center

Recruiting

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

Prostate Cancer | Oligometastatic Disease | Castrate Sensitive Prostate Cancer

United States
FBM Industria Brasileira Ltda
Azidus Brasil Scientific Research and Development Ltda

Unknown

Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.

Hypogonadism
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States, Canada
Bayer
Orion Corporation, Orion Pharma

Completed

Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (ARASENS)

Metastatic Hormone-sensitive Prostate Cancer

Belgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
Acerus Pharmaceuticals Corporation

Withdrawn

Influence of Administration Route of Testosterone on Male Fertility

Hypogonadism

Netherlands
Western University, Canada

Not yet recruiting

Testosterone and Neurovascular Control in Humans

Healthy

Canada
Sohag University

Completed

Effects of Adrenal Androgens on Gender-typed Behavior in Girls With Turner Syndrome

Turner Syndrome

Egypt
University of Pennsylvania
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

The Testosterone Trials in Older Men

Andropause

United States
Umeå University
Karolinska University Hospital; Vastra Gotaland Region; Region Jönköping County; Region Skane and other collaborators

Recruiting

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer (METRO)

Prostate Cancer Metastatic | Positron-Emission Tomography | Radiation Therapy

Sweden
Andrew J. Armstrong, MD

Completed

A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

Prostate Cancer

United States
Duke University
Astellas Pharma Inc; Medivation, Inc.

Completed

Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) (STREAM)

Prostate Cancer

United States
Duke University
Janssen Pharmaceuticals

Completed

Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer

Prostate Cancer

United States
Mỹ Đức Hospital

Completed

Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study

Poor Ovarian Response

Vietnam
UNICANCER
Sanofi; European Organisation for Research and Treatment of Cancer - EORTC; I... and other collaborators

Active, not recruiting

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer (PEACE1)

Metastatic Prostate Cancer

France, Ireland, Spain, Switzerland, Belgium, Italy, Romania
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Merck Sharp & Dohme LLC

Active, not recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)

Metastatic Hormone-Sensitive Prostate Cancer

Taiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
Merck Sharp & Dohme LLC

Active, not recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)-China Extension

Metastatic Hormone-Sensitive Prostate Cancer

China
University of Miami

Not yet recruiting

PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer (OCEAN)

Prostate Cancer | Prostate Adenocarcinoma | Hormone Sensitive Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

Advanced Cancer

United States
McGuire Research Institute
Solvay Pharmaceuticals

Completed

Effect of Testosterone Replacement on Insulin Resistance

Metabolic Syndrome | Hypogonadism

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Novartis Pharmaceuticals; Eastern Cooperative... and other collaborators

Completed

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Prostate Cancer | Metastatic Cancer

United States, Canada
Zin W Myint
Merck Sharp & Dohme LLC

Recruiting

Pembro With Radiation With or Without Olaparib

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Active, not recruiting

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

Prostate Cancer | Prostate Disease

United States
Washington University School of Medicine

Completed

Sex Steroids, Sleep, and Metabolic Dysfunction in Women (SCOR)

Obesity | Obstructive Sleep Apnea | Polycystic Ovary Syndrome (PCOS)

United States
Fudan University

Active, not recruiting

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Neoadjuvant Therapy | High-risk Prostate Cancer

China
Janssen Research & Development, LLC

Completed

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Prostate Neoplasms

Canada, France, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Netherlands, Sweden, New Zealand and more
Janssen Research & Development, LLC

Completed

Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy

Prostatic Neoplasms

Brazil
University of California, Los Angeles
National Multiple Sclerosis Society

Completed

Testosterone Treatment for Multiple Sclerosis

Multiple Sclerosis

United States
Thomas Jefferson University

Suspended

MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer

Prostate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8

United States
University of Cagliari

Unknown

Ultrasound Three-dimensional Characterization of Ovarian Morphology in Women With Polycystic Ovary Syndrome (PCOS)

Hyperandrogenism | PCOS
Mayo Clinic
National Institutes of Health (NIH)

Completed

Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men

Hypogonadism

United States
University of Maryland, Baltimore
Janssen Scientific Affairs, LLC

Recruiting

High-Risk Metachronous Oligometastatic Prostate Cancer Trial (KNIGHTS)

Prostate Cancer | Oligometastatic Disease

United States
University of Washington
GlaxoSmithKline; VA Office of Research and Development; Seattle Institute for... and other collaborators

Completed

TRADE-Testosterone Replacement and Dutasteride Effectiveness (TRADE)

Benign Prostatic Hyperplasia | Hypogonadism

United States

Search clinical trials for: Nonsteroidal Anti-Androgens

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations